HC News

• EMA approval for new drug to treat Alzheimer’s disease
• El papel del radiofísico hospitalario
• Katia Vandekerckhove, dietista- nutricionista especializada en SIBO, microbiota y metagenómica
• A clear and stable vision with cataract surgery at HC Marbella
• Ageing is a luxury, let’s not forget it
• Vårdgarantier för våra nordiska patienter
• Tomas Arrazola. Farmacéutico hospitalario superespecializado en oncología
• Advances and challenges in the fight against cancer
• HC Marbella recibe la certificación ISO 9001:2015, reafirmando su compromiso con la calidad y seguridad asistencial
• Alcohol consumption among adolescents
• More news

Betting on progress in cancer treatments

With more than 30 medical specialties, the HC Marbella International Hospital bets from Oncology Unit in more advanced therapeutic options for all patients who are treated in a multidisciplinary way. This means that all medical professionals work closely with other specialists to thoroughly evaluate each case to address the best possible solution.

ISo it is explained the head of the medical team at the hospital, Dr. Hernán Cortés-Funes, who emphasizes the purpose of this process, “featuring faster providing quality of life to people with cancer.”

In addressing, this disease is very decisive diagnosis. In this sense, the hospital will launch a camera PET / CT-Computed Tomography Emission Tomography-whose test allows better localization and demarcation of tumors. With its precision to the experts better enforcement of a certain treatment.

Also, HC Marbella has a Cancer Day Hospital to treat cancer patients can continue their therapy without being admitted. Thus, the patient may be accompanied by their families for as long as required by the process.

The hospital has a large number of highly respected consultants oncologists worldwide and is connected with different genetic profiles platforms to analyze the profile of a patient before treatment.

In this sense, the institution has agreements with the Molecular Biology Laboratory of the Hospital Universitario 12 de Octubre in Madrid, where Dr. Cortes-Funes is Chief of Medical Oncology, and maintains partnerships with other international research centers.

September 10, 2013